Use of cookies by
Norton Rose Fulbright
We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out at nortonrosefulbright.com/cookies-policy. By continuing to use this website you agree to our use of our cookies unless you have disabled them.
Guide to Canada's PM(NOC) Regulations and Data Protection with an additional section on Canada's Access to Medicines Regime | Norton Rose Fulbright

Guide to Canada's PM(NOC) Regulations and Data Protection with an additional section on Canada's Access to Medicines Regime

January 2012

Contacts

Key industry sectors

We are pleased to provide resource guides to Canada’s Patented Medicines (Notice of Compliance Regulations), Data Protection and Access to Medicines Regime. The guides provide an understanding of these regimes particularly for the benefit of the innovative pharmaceutical industry.

The Patented Medicines (Notice of Compliance Regulations) provide a summary court procedure to prevent patent infringement. The data protection provisions of the Food and Drug Regulations give eligible innovative drugs a period of market exclusivity. Finally, Canada’s implementation of the 2003 Decision of the WTO provides for the humanitarian export of medicine to the least developed and developing countries.

Download Guide to Canada’s PM(NOC) Regulations and Data Protection (pdf 24MB)